SOD1 and metabolic dysfunction-associated steatotic liver disease: The recent studies by Fathi et al. [97] showed that 3-month therapy with 30 mg elemental zinc supplement improves serum levels of insulin, insulin resistance, superoxide dismutase 1 (SOD1) and malondialdehyde (MDA), thus improving stress status in overweight/obese NAFLD patients.